Christian Antoni

14.0k total citations · 6 hit papers
49 papers, 9.3k citations indexed

About

Christian Antoni is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Christian Antoni has authored 49 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Rheumatology, 22 papers in Immunology and 13 papers in Hematology. Recurrent topics in Christian Antoni's work include Rheumatoid Arthritis Research and Therapies (27 papers), Spondyloarthritis Studies and Treatments (14 papers) and Autoimmune and Inflammatory Disorders Research (13 papers). Christian Antoni is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (27 papers), Spondyloarthritis Studies and Treatments (14 papers) and Autoimmune and Inflammatory Disorders Research (13 papers). Christian Antoni collaborates with scholars based in Germany, United States and Netherlands. Christian Antoni's co-authors include Joachim R. Kalden, Dafna D. Gladman, Ravinder N. Maini, Josef S Smolen, Marc Feldmann, Michael J. Elliott, Peter Nash, Daniel O. Clegg, Philip Mease and Burkhard F. Leeb and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Christian Antoni

47 papers receiving 8.9k citations

Hit Papers

Randomised double-blind comparison of chimeric monoclonal... 1994 2026 2004 2015 1994 1998 2005 2005 2005 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
    1994 1.3k citations Michael J. Elliott, Ravinder N. Maini et al. The Lancet profile →
  2. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
    1998 1.3k citations Ravinder N. Maini, Ferdinand C. Breedveld et al. Arthritis & Rheumatism profile →
  3. Psoriatic arthritis: epidemiology, clinical features, course, and outcome
    2005 1.2k citations Dafna D. Gladman, Christian Antoni et al. Annals of the Rheumatic Diseases profile →
  4. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
    2005 553 citations Christian Antoni, Gerald G. Krueger et al. Annals of the Rheumatic Diseases profile →
  5. Infections in patients with rheumatoid arthritis treated with biologic agents
    2005 512 citations Joachim Listing, Anja Strangfeld et al. Arthritis & Rheumatism profile →
  6. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)
    2005 502 citations Christian Antoni, Arthur Kavanaugh et al. Arthritis & Rheumatism profile →

Peers

Christian Antoni
Filip Van den Bosch Belgium
Filip De Keyser Belgium
Joachim R. Kalden Germany
Arthur Kavanaugh United States
F. C. Breedveld Netherlands
Bernhard Manger Germany
Guillermo Ruiz‐Irastorza Spain
Patrick Durez Belgium
Jane E. Salmon United States
Bruce Kirkham United Kingdom
Filip Van den Bosch Belgium
Christian Antoni
Citations per year, relative to Christian Antoni Christian Antoni (= 1×) peers Filip Van den Bosch

Countries citing papers authored by Christian Antoni

Since Specialization
Citations

This map shows the geographic impact of Christian Antoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Antoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Antoni more than expected).

Fields of papers citing papers by Christian Antoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Antoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Antoni. The network helps show where Christian Antoni may publish in the future.

Co-authorship network of co-authors of Christian Antoni

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Antoni. A scholar is included among the top collaborators of Christian Antoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Antoni. Christian Antoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raghu, Ganesh, Luca Richeldi, Bruno Crestani, et al.. (2018). SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772). European Respiratory Journal. 52(6). 1801130–1801130. 70 indexed citations
2.
Patel, Dhavalkumar D., David M. Lee, Frank Kolbinger, & Christian Antoni. (2012). Effect of IL-17A blockade with secukinumab in autoimmune diseases. Annals of the Rheumatic Diseases. 72. iii116–iii123. 248 indexed citations
3.
Grünke, Mathias, Christian Antoni, Arthur Kavanaugh, et al.. (2010). Standardization of Joint Examination Technique Leads to a Significant Decrease in Variability Among Different Examiners. The Journal of Rheumatology. 37(4). 860–864. 31 indexed citations
4.
Bijl, A. E. van der, Ferdinand C. Breedveld, Christian Antoni, et al.. (2008). An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status. Clinical Rheumatology. 27(8). 1021–1028. 69 indexed citations
5.
Heijde, Désirée van der, Arthur Kavanaugh, Dafna D. Gladman, et al.. (2007). Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2. Arthritis & Rheumatism. 56(8). 2698–2707. 140 indexed citations
6.
Ogilvie, Adaling, Matthias Lüftl, Christian Antoni, et al.. (2006). Leukocyte Infiltration and mRNA Expression of IL-20, IL-8 and TNF-R p60 in Psoriatic Skin is Driven by TNF-α. International Journal of Immunopathology and Pharmacology. 19(2). 271–278. 37 indexed citations
7.
Gladman, Dafna D., et al.. (2005). Infliximab therapy improves health-related quality of life in patients with psoriatic arthritis. Journal of the American Academy of Dermatology. 52(3). P189–P189. 2 indexed citations
8.
Listing, Joachim, Anja Strangfeld, S. Kary, et al.. (2005). Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis & Rheumatism. 52(11). 3403–3412. 512 indexed citations breakdown →
9.
Antoni, Christian, Arthur Kavanaugh, Bruce Kirkham, et al.. (2005). Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Arthritis & Rheumatism. 52(4). 1227–1236. 502 indexed citations breakdown →
10.
Zink, A., Joachim Listing, S. Kary, et al.. (2005). Treatment continuation in patients receiving biological agents or conventional DMARD therapy. Annals of the Rheumatic Diseases. 64(9). 1274–1279. 126 indexed citations
11.
Antoni, Christian & Bernhard Manger. (2004). Biotechnologische Medikamente bei entz�ndlichen Erkrankungen. Der Internist. 45(S01).
12.
Dechant, Claudia, et al.. (2004). Langzeitergebnisse einer TNF-Blockade beim Morbus Still im Erwachsenenalter. DMW - Deutsche Medizinische Wochenschrift. 129(23). 1308–1312. 27 indexed citations
13.
Straub, Rainer H., Georg Pongratz, Jürgen Schölmerich, et al.. (2003). Long‐term anti–tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion. Arthritis & Rheumatism. 48(6). 1504–1512. 45 indexed citations
14.
Cursiefen, Claus, Mathias Grünke, Claudia Dechant, et al.. (2002). Multiple bilateral eyelid molluscum contagiosum lesions associated with TNFα-antibody and methotrexate therapy. American Journal of Ophthalmology. 134(2). 270–271. 38 indexed citations
15.
Antoni, Christian, et al.. (2001). Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Annals of the Rheumatic Diseases. 60. iii55–iii57. 107 indexed citations
16.
Charles, P., M. J. Elliott, Diana Davis, et al.. (1999). Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.. PubMed. 163(3). 1521–8. 440 indexed citations
17.
Charles, P., Michael J. Elliott, Diana Davis, et al.. (1999). Regulation of Cytokines, Cytokine Inhibitors, and Acute-Phase Proteins Following Anti-TNF-α Therapy in Rheumatoid Arthritis. The Journal of Immunology. 163(3). 1521–1528. 376 indexed citations
18.
Mahler, Vera, Christian Antoni, Grant J. Anhalt, et al.. (1998). Graft-versus-Host-Like Mucocutaneous Eruptions with Serological Features of Paraneoplastic Pemphigus and Systemic Lupus erythematosus in a Patient with Non-Hodgkin’s Lymphoma. Dermatology. 197(1). 78–83. 15 indexed citations
19.
Lorenz, Hanns‐Martin, Christian Antoni, Thomas Valerius, et al.. (1996). In vivo blockade of TNF-α by intravenous infusion of a chimeric monoclonal TNF-α antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects. The Journal of Immunology. 156(4). 1646–1653. 135 indexed citations
20.
Elliott, Michael J., Ravinder N. Maini, Marc Feldmann, et al.. (1994). Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. The Lancet. 344(8930). 1105–1110. 1339 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Filip Van den Bosch Breakdown of academic impact, for papers by Filip De Keyser Breakdown of academic impact, for papers by Joachim R. Kalden Breakdown of academic impact, for papers by Arthur Kavanaugh Breakdown of academic impact, for papers by F. C. Breedveld Breakdown of academic impact, for papers by Bernhard Manger Breakdown of academic impact, for papers by Guillermo Ruiz‐Irastorza Breakdown of academic impact, for papers by Patrick Durez Breakdown of academic impact, for papers by Jane E. Salmon Breakdown of academic impact, for papers by Bruce Kirkham
Rankless by CCL
2026